Story perspectives

Sucralose Intake Linked to Reduced Cancer Immunotherapy Success

9/8/2025

40 6

Summary

Story summary

Research from the University of Pittsburgh and UPMC Hillman Cancer Center shows sucralose may hinder cancer immunotherapy in melanoma and lung cancer patients.
High sucralose intake links to reduced therapeutic responses and lower survival rates.
Arginine supplementation may mitigate sucralose's adverse effects, as demonstrated in mouse models.
Sucralose disrupts gut microbiota, lowering arginine levels essential for T cell function.
A study of 132 patients confirmed sucralose's negative impact on immunotherapy effectiveness.

1 of 1

Story summary

Research from the University of Pittsburgh and UPMC Hillman Cancer Center shows sucralose may hinder cancer immunotherapy in melanoma and lung cancer patients.
High sucralose intake links to reduced therapeutic responses and lower survival rates.
Arginine supplementation may mitigate sucralose's adverse effects, as demonstrated in mouse models.
Sucralose disrupts gut microbiota, lowering arginine levels essential for T cell function.
A study of 132 patients confirmed sucralose's negative impact on immunotherapy effectiveness.